JUPITER – Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

JUPITER – Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

• There were significant flaws with this study. Most importantly, the estimation of a treatment benefit favoring statins may have been overestimated due to the early termination of this study.

• No guidelines have been published advocating statin therapy for primary prevention in patients with baseline characteristics similar to this study cohort.

Infographic

Reference

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008 Nov 20;359(21):2195-207.

About the author 

MyEndoConsult

The MyEndoconsult Team. A group of physicians dedicated to endocrinology and internal medicine education.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Pathophysiology Videos


Videos

  • Learn Basic Physiology
  • Pathophysiology (Advanced Concepts)
  • Clinical Correlates
>